Cocrystal development is an increasingly popular step in the drug development process. By forming cocrystals – crystalline complexes formed by two (or more) separate molecular entities – drug developers can modify the physical properties of an API while preserving the benefits of a crystalline solid form.
• Unique API intellectual property protection
• Increased formulation stability
• Enhanced physiochemical properties